Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Medicus Pharma Ltd. - Common Stock (NQ:MDCX)

3.120 -0.160 (-4.88%)
Delayed Quote Updated: 4:00 PM EDT, Oct 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 69,943
Open 3.080
Bid (Size) 3.020 (100)
Ask (Size) 3.250 (200)
Prev. Close 3.280
Today's Range 2.921 - 3.250
52wk Range 2.921 - 139.00
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Friday's after hours session: top gainers and losers ↗
Via Chartmill
These stocks are moving in today's pre-market session ↗
Via Chartmill

Performance

52-Week Range 97.8% below 52-week high
3.120
2.9252W Low 139.0052W High
1 Week 46.0% below 1-week high
2.921W Low 5.781W High

Medicus Pharma Ltd. - Common Stock (MDCX) traded between $2.92 and $139.00 over the past 52 weeks and last traded at $3.12, 97.8% below its 52-week high. Over the past week it ranged between $2.92 and $5.78.

Past 12 Months
-38.8%
-60.8%
-82.1%
-79.3%
-96.1%
-97.4%
1W -$1.97
1M -$4.84
3M -$14.30
6M -$11.98
YTD -$76.88
1Y -$115.88

MDCX was -97.4% over the past year, -79.3% over six months, -96.1% year to date, -38.8% in the last week.

12 Months vs Market
MDCX
-97.4%
DIA
+11.4%
SPY
+16.2%
QQQ
+21.9%
IWM
+9.5%

Over the past 12 months MDCX returned -97.4% versus DIA (Dow) +11.4%, SPY (S&P 500) +16.2%, QQQ (Nasdaq 100) +21.9% and IWM (Russell 2000) +9.5%.

Volume & Liquidity 0.71× 3-mo avg
Today 69,943 3-mo avg 98.9K
1W
179.2K
1M
92.3K
3M
98.9K
6M
90.2K
YTD
82.9K
1Y
66.3K

MDCX most recently traded 69,943 shares against a 3-month average daily volume of 98.9K.

More News

Read More
Top stock movements in today's session. ↗
Via Chartmill
Let's take a look at the stocks that are in motion in today's session. ↗
Via Chartmill
Traders are paying attention to the gapping stocks in Thursday's session. ↗
Via Chartmill
Thursday's pre-market session: top gainers and losers ↗
Via Chartmill
News headline image
Medicus Pharma Highlights Three Years of Progress and Outlines Potential Path to Long Term Value
From Medicus Pharma Ltd
Via GlobeNewswire
What's going on in today's after hours session ↗
Via Chartmill
News headline image
Medicus Pharma Submits Optimized Teverelix® Registrational Protocol to FDA to Create Partner Ready Program in Advanced Prostate Cancer
From Medicus Pharma Ltd
Via GlobeNewswire
News headline image
Medicus Pharma Announces Exclusive Development Focus for SkinJect® in Gorlin Syndrome Following Commercial, Clinical and Regulatory Assessment
From Medicus Pharma Ltd
Via GlobeNewswire
Unusual volume stocks are being observed in Thursday's session. ↗
Via Chartmill
News headline image
Medicus Pharma Publishes Abridged Final Phase 2 SkinJect® Clinical Study Report (CSR) Results Identifying 200 µg D-MNA Patch as the Lead Development Dose
From Medicus Pharma Ltd
Via GlobeNewswire
Unusual volume stocks in Tuesday's session ↗
Via Chartmill
News headline image
Medicus Pharma Advances Transformation into a Precision Oncology-Led Biotechnology Company
From Medicus Pharma Ltd
Via GlobeNewswire
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
Via Chartmill
Check out the stocks that are attracting the most attention and driving market activity. ↗
Via Chartmill
Thursday's session: top gainers and losers ↗
Via Chartmill
Gapping stocks in Thursday's session ↗
Via Chartmill
Wondering what's happening in today's pre-market session? ↗
Via Chartmill
News headline image
Medicus Pharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update
From Medicus Pharma Ltd
Via ACCESS Newswire
News headline image
Medicus Pharma Appoints Dr. Faisal Mehmud as Chief Executive Officer of Antev Limited, United Kingdom
From Medicus Pharma Ltd
Via GlobeNewswire
News headline image
Medicus Pharma Receives UAE Department of Health (DOH) Authorization to proceed with Novel Prospective Genomics Guided Precision Medicine Study Evaluating Teverelix® in Women with Endometriosis
From Medicus Pharma Ltd
Via GlobeNewswire
News headline image
Medicus Pharma Receives FDA “Study May Proceed” Letter for NDA-Enabling Registrational SkinJect® Study in Patients with Gorlin Syndrome
From Medicus Pharma Ltd
Via GlobeNewswire
News headline image
New to The Street to Broadcast Nationwide on Bloomberg Television Tonight at 6:30 PM ET Featuring RHINO Bitcoin, Marina Decisions, Medicus Pharma and Virtuix Holdings
From New to The Street
Via ACCESS Newswire
Top movers in Friday's after hours session ↗
Via Chartmill

Frequently Asked Questions

Is Medicus Pharma Ltd. - Common Stock publicly traded?
Yes, Medicus Pharma Ltd. - Common Stock is publicly traded.
What exchange does Medicus Pharma Ltd. - Common Stock trade on?
Medicus Pharma Ltd. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Medicus Pharma Ltd. - Common Stock?
The ticker symbol for Medicus Pharma Ltd. - Common Stock is MDCX on the Nasdaq Stock Market
What is the current price of Medicus Pharma Ltd. - Common Stock?
The current price of Medicus Pharma Ltd. - Common Stock is 3.120
When was Medicus Pharma Ltd. - Common Stock last traded?
The last trade of Medicus Pharma Ltd. - Common Stock was at 10/14/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.